☆ 4.7 Editorial Material

Imaging-based Diagnostic and Therapeutic Strategies for Prostate Cancer in the Coming Decades

RADIOLOGY (2023)

Related references

Note: Only part of the references are listed.

Editorial Material Radiology, Nuclear Medicine & Medical Imaging

Genitourinary Imaging in 2040

Vicky Goh

RADIOLOGY (2023)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

PI-RADS: Where Next?

Baris Turkbey et al.

Summary: Prostate MRI plays a crucial role in the clinical management of localized prostate cancer, providing support for biopsy decisions and guidance. This review article discusses the current use of PI-RADS, its limitations, controversies, and summarizes research aimed at enhancing future versions of this system.

RADIOLOGY (2023)

Add to Collection

Editorial Material Radiology, Nuclear Medicine & Medical Imaging

Adnexal Lesion Imaging: Past, Present, and Future

Elizabeth A. Sadowski et al.

Summary: Imaging plays a crucial role in the diagnosis of adnexal lesions, aiding in the determination of lesion nature and potential cancer risk, thereby reducing unnecessary surgical interventions.

RADIOLOGY (2023)

Add to Collection

Article Oncology

Recent Advances in the Management of Metastatic Prostate Cancer

Soo Yeon Kim et al.

Summary: The management of metastatic prostate cancer has undergone a revolution with the introduction of new agents and the repurposing of existing ones. These novel therapies have shown improved outcomes and have received approval. The ongoing investigation of multiple new agents is expected to further improve survival outcomes for patients in the coming years.

JCO ONCOLOGY PRACTICE (2022)

Add to Collection

Review Urology & Nephrology

Is Grade Group 1 (Gleason score 3+3=6) adenocarcinoma of the prostate really cancer?

Jonathan I. Epstein

Summary: There is controversy over whether Grade Group 1 (GG1) prostate cancer is truly cancer. Recent findings support renaming GG1 with a noncancerous diagnosis due to fear of the term cancer and the indolence of GG1. However, there is also support for designating GG1 as cancer as it shares morphological and molecular characteristics with higher grade prostate cancer.

CURRENT OPINION IN UROLOGY (2022)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Multiparametric bone MRI can improve CT-guided bone biopsy target selection in cancer patients and increase diagnostic yield and feasibility of next-generation tumour sequencing

Ricardo Donners et al.

Summary: This study evaluated the use of multiparametric bone MRI in identifying bone metastases. The combination of DWI signal, ADC, and rFF proved effective in identifying tumor-positive biopsies and increasing the feasibility of next-generation genomic sequencing.

EUROPEAN RADIOLOGY (2022)

Add to Collection

Editorial Material Urology & Nephrology

Magnetic Resonance Imaging-guided Adaptive Radiotherapy for Urological Cancers: What Urologists Should Know

Linda G. W. Kerkmeijer et al.

EUROPEAN UROLOGY (2022)

Add to Collection

Article Urology & Nephrology

A Prospective Multicenter Comparison Study of Risk-adapted Ultrasound-directed and Magnetic Resonance Imaging-directed Diagnostic Pathways for Suspected Prostate Cancer in Biopsy-naive Men

Ivo M. Wagensveld et al.

Summary: This study compared the diagnostic performance of a risk-based ultrasound-directed pathway and a magnetic resonance imaging (MRI)-directed pathway. The results showed that they performed equally well in detecting GG ≥ 2 cancers, with the risk-based ultrasound-directed pathway performing well if MRI capacity is not available. The study emphasized the importance of utilizing MRI in risk assessment to reduce unnecessary biopsies and detect fewer irrelevant cancers.

EUROPEAN UROLOGY (2022)

Add to Collection

Article Medicine, General & Internal

Prostate Cancer Screening with PSA and MRI Followed by Targeted Biopsy Only

Jonas Hugosson et al.

Summary: MRI-directed targeted biopsy for prostate cancer screening reduces the risk of overdiagnosis by half compared to systematic biopsy, but may delay the detection of intermediate-risk tumors in a small proportion of patients.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Avoiding Unnecessary Biopsy after Multiparametric Prostate MRI with VERDICT Analysis: The INNOVATE Study

Saurabh Singh et al.

Summary: VERDICT MRI analysis can better classify clinically significant prostate cancer compared to the use of apparent diffusion coefficient and prostate-specific antigen density.

RADIOLOGY (2022)

Add to Collection

Review Surgery

Robot-assisted radical prostatectomy: Advancements in surgical technique and perioperative care

Isaac Palma-Zamora et al.

Summary: In this review, we examined the evolving strategies, practice patterns, and recent advancements aimed at improving perioperative and surgical outcomes in patients undergoing robot-assisted radical prostatectomy for localized prostate cancer.

FRONTIERS IN SURGERY (2022)

Add to Collection

Article Urology & Nephrology

Histological comparison between predictive value of preoperative 3-T multiparametric MRI and68Ga-PSMA PET/CT scan for pathological outcomes at radical prostatectomy and pelvic lymph node dissection for prostate cancer

Anthony Franklin et al.

Summary: The study evaluated the predictive ability of preoperative mpMRI and Ga-68-PSMA PET/CT scan on pathological outcomes, identifying men with <5% risk of LNM; Ga-68-PSMA PET/CT was more sensitive in LNM detection, and men with negative results had lower risk compared to traditional calculators.

BJU INTERNATIONAL (2021)

Add to Collection

Article Oncology

Focal Boost to the Intraprostatic Tumor in External Beam Radiotherapy for Patients With Localized Prostate Cancer: Results From the FLAME Randomized Phase III Trial

Linda G. W. Kerkmeijer et al.

Summary: The study found that focal boosting of the macroscopic visible tumor with external beam radiotherapy increases biochemical disease-free survival in patients with localized intermediate- and high-risk prostate cancer. There were no significant differences in prostate cancer-specific survival, overall survival, toxicity, and health-related quality of life between the focal boost arm and the standard treatment arm.

JOURNAL OF CLINICAL ONCOLOGY (2021)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Head-to-Head Comparison of 68Ga-Prostate-Specific Membrane Antigen PET/CT and Ferumoxtran-10-Enhanced MRI for the Diagnosis of Lymph Node Metastases in Prostate Cancer Patients

Melline G. M. Schilham et al.

Summary: Accurate assessment of lymph node metastases in prostate cancer patients is crucial. PSMA PET/CT and nano-MRI are imaging modalities with high potential for identifying LN metastases. This study compared the results of these modalities, finding that nano-MRI detected more suspicious LNs, especially smaller ones, across all anatomical regions of the pelvis. It suggests that nano-MRI could complement PSMA PET/CT in imaging PCa patients, but further investigation is needed.

JOURNAL OF NUCLEAR MEDICINE (2021)

Add to Collection

Article Oncology

Medical imaging and nuclear medicine: a Lancet Oncology Commission

Hedvig Hricak et al.

Summary: The study demonstrates that the scale-up of imaging technology can significantly reduce cancer-related deaths globally and save a substantial number of life-years. Comprehensive scaling up of imaging, treatment, and care quality can save billions of dollars globally between 2020 and 2030, alleviating the global burden of cancer.

LANCET ONCOLOGY (2021)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Artificial Intelligence-assisted Prostate Cancer Diagnosis: Radiologic-Pathologic Correlation

Lidia Alcala Mata et al.

Summary: The traditional diagnostic pathway for prostate cancer has limitations, and new technologies like multiparametric MRI are being widely adopted to improve diagnostic methods. While new diagnostic pathways aim to enhance diagnostic accuracy and efficiency, there are still limitations, particularly regarding the subjectivity and reproducibility of histopathologic grading.

RADIOGRAPHICS (2021)

Add to Collection

Article Oncology

Population-Based Prostate Cancer Screening With Magnetic Resonance Imaging or Ultrasonography The IP1-PROSTAGRAM Study

David Eldred-Evans et al.

Summary: In this cohort study, MRI with a score of 4 or 5 as a positive test result detected more clinically significant prostate cancer cases compared to PSA testing alone at 3 ng/mL or higher, without increasing unnecessary biopsies or overdiagnosing clinically insignificant cancer. Ultrasonography did not show superior performance to PSA testing alone.

JAMA ONCOLOGY (2021)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

ESUR/ESUI position paper: developing artificial intelligence for precision diagnosis of prostate cancer using magnetic resonance imaging

Tobias Penzkofer et al.

Summary: Artificial intelligence is crucial for the successful deployment of community-wide MRI-driven prostate cancer diagnosis by ensuring high specificity, biopsy avoidance, and integration into radiologists' workflow. Further development efforts are needed to make AI systems as clinical decision-making tools for a wider adoption of the MRI-directed approach.

EUROPEAN RADIOLOGY (2021)

Add to Collection

Review Urology & Nephrology

Prostate-specific Antigen Testing as Part of a Risk-Adapted Early Detection Strategy for Prostate Cancer: European Association of Urology Position and Recommendations for 2021

Hendrik Van Poppel et al.

Summary: The European Association of Urology in 2021 presented a risk-adapted strategy for early prostate cancer detection using PSA testing, risk calculators, and multiparametric magnetic resonance imaging. This approach aims to reduce overdiagnosis/overtreatment and improve quality of life by diagnosing significant cancer early.

EUROPEAN UROLOGY (2021)

Add to Collection

Article Oncology

Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial

Tobias Nordstrom et al.

Summary: This study compared traditional screening methods for prostate cancer with a diagnostic strategy combining blood-based risk prediction and MRI-targeted biopsies. The use of the Stockholm3 test was found to be non-inferior to PSA for the detection of clinically significant prostate cancer, while also detecting a similar number of low-grade cancers. Additionally, the combination of Stockholm3 with MRI-targeted biopsies led to higher detection rates of significant cancers and lower rates of low-grade cancers compared to standard screening methods.

LANCET ONCOLOGY (2021)

Add to Collection

Article Medicine, General & Internal

Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer

Oliver Sartor et al.

Summary: The radioligand therapy with Lu-177-PSMA-617 prolonged both imaging-based progression-free survival and overall survival in patients with PSMA-positive metastatic castration-resistant prostate cancer when added to standard care. Adverse events were more common with Lu-177-PSMA-617 but did not significantly impact quality of life.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Review Urology & Nephrology

Prostate Magnetic Resonance Imaging, with or Without Magnetic Resonance Imaging-targeted Biopsy, and Systematic Biopsy for Detecting Prostate Cancer: A Cochrane Systematic Review and Meta-analysis

Frank-Jan H. Drost et al.

EUROPEAN UROLOGY (2020)

Add to Collection

Article Urology & Nephrology

Update of the Standard Operating Procedure on the Use of Multiparametric Magnetic Resonance Imaging for the Diagnosis, Staging and Management of Prostate Cancer

Marc A. Bjurlin et al.

JOURNAL OF UROLOGY (2020)

Add to Collection

Article Oncology

Optimum Imaging Strategies for Advanced Prostate Cancer: ASCO Guideline

Edouard J. Trabulsi et al.

JOURNAL OF CLINICAL ONCOLOGY (2020)

Add to Collection

Article Urology & Nephrology

The Movember Prostate Cancer Landscape Analysis: an assessment of unmet research needs

Michelle M. Kouspou et al.

NATURE REVIEWS UROLOGY (2020)

Add to Collection

Article Endocrinology & Metabolism

Prostate cancer-specific mortality burden by risk group among men with localized disease: Implications for research and clinical trial priorities

Edward Christopher Dee et al.

PROSTATE (2020)

Add to Collection

Article Oncology

Overview of artificial intelligence-based applications in radiotherapy: Recommendations for implementation and quality assurance

Liesbeth Vandewinckele et al.

RADIOTHERAPY AND ONCOLOGY (2020)

Add to Collection

Review Urology & Nephrology

Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2

Baris Turkbey et al.

EUROPEAN UROLOGY (2019)

Add to Collection

Article Urology & Nephrology

A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer

Jonas Hugosson et al.

EUROPEAN UROLOGY (2019)

Add to Collection

Review Urology & Nephrology

Technologies for image-guided surgery for managing lymphatic metastases in prostate cancer

Fijs W. B. van Leeuwen et al.

NATURE REVIEWS UROLOGY (2019)

Add to Collection

Article Urology & Nephrology

The Diverse Genomic Landscape of Clinically Low-risk Prostate Cancer

Matthew R. Cooperberg et al.

EUROPEAN UROLOGY (2018)

Add to Collection

Article Medicine, General & Internal

Effect of a Low-Intensity PSA-Based Screening Intervention on Prostate Cancer Mortality The CAP Randomized Clinical Trial

Richard M. Martin et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)

Add to Collection

Review Medicine, General & Internal

Screening for Prostate Cancer US Preventive Services Task Force Recommendation Statement

David C. Grossman et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)

Add to Collection

Article Oncology

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Freddie Bray et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2018)

Add to Collection

© Peeref 2019-2024. All rights reserved.